New cream aims to fade dark spots naturally
NCT ID NCT05986123
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a cream made from natural plant extracts, niacinamide, and arbutin to see if it safely lightens dark spots (post-inflammatory hyperpigmentation) on the skin. Twenty-five healthy Malaysian adults used the cream twice daily for 20 weeks. Researchers measured changes in skin spots and checked for side effects.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Topical cream containing niacinamide, arbutin, Scutellaria Baicalensis Root Extract, Centella Asiatica Extract, and Camellia Sinensis Leaf Extract
- What this could lead to
- If it works, this could offer a safe, natural option for fading dark spots left after skin injuries or inflammation.
- What could go wrong
- This was a small, completed study with only 25 healthy adults, so results may not apply to everyone. The cream is cosmetic and not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, 47810, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test